ArticlePloS one2021

Evaluation of the antiproliferative effects of the HASPIN inhibitor CHR-6494 in breast cancer cell lines.

Hisayo Nishida-Fukuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.